Posted by Michael Wonder on 04 Feb 2020
Interferon, Kaletra to get insurance benefit for new coronavirus treatment
4 February 2020 - The government said it would allow health insurance benefits for patients who received interferon or combo therapy of lopinavir plus ritonavir, for treating the confirmed or suspected new coronavirus (2019-nCoV) infection.
The Ministry of Health and Welfare announced a revision of details in reimbursement criteria and methods on Monday. The revision added 2019-nCov to the existing section of the MERS (Middle East Respiratory Syndrome)-CoV.
The government also amended the details to allow a full reimbursement for a patient, instead of asking a patient to pay part of the cost that exceeds the limited use of the reimbursable drug.
